Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 6, 2022; 10(13): 4249-4263
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4249
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4249
Coexistence of meningioma and other intracranial benign tumors in non-neurofibromatosis type 2 patients: A case report and review of literature
Tian-Hao Hu, Run Wang, Hai-Yun Wang, Yi-Fu Song, Zi-Xun Wang, Yu-Zhou Duan, Sheng Han, Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Juan-Han Yu, Department of Pathology, China Medical University, Shenyang 110001, Liaoning Province, China
Ting Liu, Department of Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Author contributions: Hu TH, Wang R, Duan YZ, Liu T and Han S performed the data acquisition and prepared the figures; Hu TH, Wang HY and Song YF prepared the manuscript and followed up the patients; Yu JH and Wang ZX performed histopathology examination of the patients; Hu TH and Han S designed the report; All authors contributed to the article and approved the submitted version.
Supported by the LiaoNing Revitalization Talents Program , No. XLYC1807253 ; and the National Natural Science Foundation of China , No. 81772653 .
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sheng Han, Doctor, MD, PhD, Academic Research, Surgeon, Surgical Oncologist, Department of Neurosurgery, The First Hospital of China Medical University, No. 155 Nanjing Street, Heping District, Shenyang 110001, Liaoning Province, China.
Received: October 2, 2021
Peer-review started: October 2, 2021
First decision: October 22, 2021
Revised: October 29, 2021
Accepted: March 15, 2022
Article in press: March 15, 2022
Published online: May 6, 2022
Processing time: 210 Days and 1.4 Hours
Peer-review started: October 2, 2021
First decision: October 22, 2021
Revised: October 29, 2021
Accepted: March 15, 2022
Article in press: March 15, 2022
Published online: May 6, 2022
Processing time: 210 Days and 1.4 Hours
Core Tip
Core Tip: The simultaneous occurrence of meningioma and other intracranial primary benign tumors is rare, especially in non-neurofibromatosis type 2, and there is limited guidance for the management of such patients. In this study, we report a series of 5 patients with coexistence of meningioma and other intracranial benign tumors, including subependymoma and pituitary adenoma.